tiprankstipranks
Trending News
More News >
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market

PTC Therapeutics (PTCT) Income Statement

Compare
405 Followers

PTC Therapeutics Income Statement

Last quarter (Q3 2025), PTC Therapeutics's total revenue was $211.01M, an increase of 7.23% from the same quarter last year. In Q3, PTC Therapeutics's net income was $15.90M. See PTC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 806.78M$ 937.82M$ 698.80M$ 538.59M$ 380.77M
Gross Profit
$ 749.38M$ 872.34M$ 654.12M$ 506.26M$ 361.82M
Operating Expenses
$ 1.05B$ 1.31B$ 1.10B$ 880.71M$ 793.59M
Depreciation and Amortization
$ 75.66M$ 236.59M$ 128.84M$ 64.13M$ 43.49M
EBITDA
$ -120.46M$ -330.34M$ -367.78M$ -368.18M$ -303.09M
Operating Income
$ -302.57M$ -439.50M$ -447.41M$ -374.44M$ -431.77M
Other Income/Expenses
$ -60.55M$ -256.61M$ -140.08M$ -143.90M$ 28.84M
Pretax Income
$ -363.12M$ -696.11M$ -587.49M$ -518.34M$ -402.93M
Net Income
$ -363.30M$ -626.60M$ -559.02M$ -523.90M$ -438.16M
Per Share Metrics
Basic EPS
$ -4.73$ -8.37$ -7.79$ -7.43$ -6.64
Diluted EPS
$ -4.73$ -8.37$ -7.79$ -7.43$ -6.64
Weighted Average Shares Outstanding
76.85M 74.84M 71.73M 70.47M 66.03M
Weighted Average Shares Outstanding (Diluted)
76.85M 74.84M 71.73M 70.47M 66.03M
Currency in USD

PTC Therapeutics Earnings and Revenue History